Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. department of health
Show results for

Refine by

Department Of Health Articles & Analysis

180 news found

Virgin Islands Department of Health Temporarily Closes Hotel due to Legionella Concerns

Virgin Islands Department of Health Temporarily Closes Hotel due to Legionella Concerns

Last month, the U.S. Virgin Islands Department of Health announced it had issued an immediate Cease-and-Desist Order to a hotel in St. ...

ByCochrane & Associates, LLC


Lead Poisoning Awareness Campaign for Adults Launched by New York State Department of Health

Lead Poisoning Awareness Campaign for Adults Launched by New York State Department of Health

The New York State Department of Health recently announced it had launched the Don't Bring Lead Home public health awareness campaign to educate New Yorkers about the dangers of lead exposure in certain occupations. ...

ByCochrane & Associates, LLC


Summary of Parliamentary Debate on Hospice Funding

Summary of Parliamentary Debate on Hospice Funding

You can watch the whole debate and the response from MP Helen Whately, Minister of State (Department of Health and Social Care) here. Post Debate on Hospice Funding: Health and Social Care Committee Meeting Following the parliamentary debate on hospice funding in the House of Commons, a Health and Social Care Committee ...

ByVantage Software


Infection Control Resources to Safeguard Patients from Vancomycin-Resistant Enterococci and Other Pathogens

Infection Control Resources to Safeguard Patients from Vancomycin-Resistant Enterococci and Other Pathogens

The New York State Department of Health (NYSDOH) describes enterococci as part of the normal flora in the intestinal tract and also a common cause of nosocomial infections. ...

ByCochrane & Associates, LLC


World TB Day and Infection Control Resources in New York City to Help Prevent New Cases

World TB Day and Infection Control Resources in New York City to Help Prevent New Cases

The New York City Department of Health and Mental Hygiene (NYC Health) warns that tuberculosis (TB) is still a life-threatening problem in the city. ...

ByCochrane & Associates, LLC


BARDA-funded Intranasal Antibody Cocktail for COVID-19 Shows Promise in a Preclinical Study

BARDA-funded Intranasal Antibody Cocktail for COVID-19 Shows Promise in a Preclinical Study

This project has been funded in whole or in part with Federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority, under Contract No. 75A50122C00025. ...

ByLumen Bioscience, Inc.


Structure-Based Search for Novel Antihypercholestrolemic Agents

Structure-Based Search for Novel Antihypercholestrolemic Agents

DESCRIPTION (provided by applicant): Heart disease is the leading cause of death for both men and women in the US, accounting for nearly 40% of all annual deaths. A high cholesterol level is a well-known risk factors for heart disease. Although blood cholesterol can be lowered using a number of marketed drugs, of which statins are the leading drugs, only 38% of patients taking these drugs are ...

ByShifa Biomedical Corporation


Development of Oral Small Molecule PCSK9 Antagonist

Development of Oral Small Molecule PCSK9 Antagonist

Abstract Project Summary Abstract The epidemic of cardiovascular diseaseCVDis a global phenomenon that remains the number one cause of death throughout the worldkilling nearlymillion people per yeara number that is expected to grow tomillion byA high cholesterol level is well known risk factors for heart diseaseAlthough blood cholesterol can be lowered using a number of marketed drugsof which ...

ByShifa Biomedical Corporation


Novel Modulators of LDL Metabolism

Novel Modulators of LDL Metabolism

DESCRIPTION provided by applicant Heart disease is the leading cause of death for both men and women in the US accounting for nearly of all annual deaths A high cholesterol level is well known risk factors for heart disease Although blood cholesterol can be lowered using a number of marketed drugs of which statins are the leading drugs only of patients taking these drugs are achieving the low ...

ByShifa Biomedical Corporation


SIGA Provides Update on Progress in Clinical Trials to Assess Use of TPOXX ® (tecovirimat) for Treatment of Monkeypox

SIGA Provides Update on Progress in Clinical Trials to Assess Use of TPOXX ® (tecovirimat) for Treatment of Monkeypox

NEW YORK, Oct. 12, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today provided an update on the status of multiple clinical trials now underway to assess the safety and efficacy of TPOXX to treat monkeypox. In recent weeks, randomized, placebo-controlled clinical trials were initiated in ...

BySIGA Technologies, Inc.


ARAI-2PAM Barda Procurement Award

ARAI-2PAM Barda Procurement Award

Aktiv Pharma Group (Aktiv) today announced a procurement contract award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). Under this contract (number 75A50122C00082), awarded under the 2004 Project ...

ByAktiv Pharma Group, Inc


Enalare Therapeutics Receives Orphan Drug Designation From the U.S. FDA on ENA-001 for the Treatment of Apnea of Prematurity (AoP)

Enalare Therapeutics Receives Orphan Drug Designation From the U.S. FDA on ENA-001 for the Treatment of Apnea of Prematurity (AoP)

ENA-001 is also being developed in an Intramuscular ("IM") formulation in partnership with the Biomedical Advanced Research and Development Authority ("BARDA"), part of the Administration for Strategic Preparedness and Response in the U.S. Department of Health and Human Services (contract number 75A50122C00072). ...

ByEnalare Therapeutics Inc.


Enalare Therapeutics Receives an Additional Award Worth Up to $50 Million From BARDA, Expanding Its Partnership in Development of ENA-001

Enalare Therapeutics Receives an Additional Award Worth Up to $50 Million From BARDA, Expanding Its Partnership in Development of ENA-001

The Funding Supports Development of an Intramuscular ENA-001 From Pre-Clinical Toxicology Through Filing for Approval in the United States Enalare Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to developing novel compounds for the treatment of life-threatening critical care diseases and community medical threats, announced today that it has received a contract from the ...

ByEnalare Therapeutics Inc.


SIGA Announces BARDA Exercise of Procurement Options Valued at Approximately $26 Million for IV TPOXX®

SIGA Announces BARDA Exercise of Procurement Options Valued at Approximately $26 Million for IV TPOXX®

(SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced the exercise of procurement options under its 75A50118C00019 (19C) contract with the U.S. Department of Health and Human Services for the delivery to the U.S. government of intravenous (IV) formulation of TPOXX treatment courses valued at approximately $26 million . ...

BySIGA Technologies, Inc.


Berkshire Biomedical Awarded NIH Research Grant to Support Continued Development of the COPA System for Automated at Home Methadone Administration

Berkshire Biomedical Awarded NIH Research Grant to Support Continued Development of the COPA System for Automated at Home Methadone Administration

About the National Institute on Drug Abuse (NIDA) NIDA is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world's research on the health aspects of drug use and addiction. ...

ByBerkshire Biomedical


Diamyd Medical joins international consortium in Type 1 Diabetes

Diamyd Medical joins international consortium in Type 1 Diabetes

Critical Path Institute is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) and is 54.2% funded by the FDA/HHS, totaling $13,239,950, and 45.8% funded by non-government source(s), totaling $11,196,634. ...

ByDiamyd Medical AB


Aktiv Pharma Group Receives Grant Funding to Develop Tranexamic Acid Autoinjector

Aktiv Pharma Group Receives Grant Funding to Develop Tranexamic Acid Autoinjector

Aktiv Pharma Group (Aktiv) announced today a grant award from the U.S. Department of Defense (DOD) Defense Health Agency (DHA) Joint Program Committee 6/Combat Casualty Care Research Program (JPC-6/CCCRP) [1] for the continued development of a tranexamic acid (TXA) autoinjector, targeting proposed indications related to prehospital treatment of severe bleeding. ...

ByAktiv Pharma Group, Inc


NewGen Surgical Signs HHS Pledge to Mobilize Healthcare Sector to Reduce Emissions

NewGen Surgical Signs HHS Pledge to Mobilize Healthcare Sector to Reduce Emissions

Surgical has signed the Department of Health and Human Services (HHS) climate pledge initiative NewGen in partnership with the White House to mobilize the healthcare sector to reduce carbon emissions. ...

ByNewGen Surgical


Vedanta Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting

Vedanta Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting

Vedanta Biosciences received a $5.4 million research award from the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) in 2017 and a contract of up to $76.9 million from the Biomedical Advanced Research and Development Authority (contract number 75A50120C00177) within the U.S. Department of Health and Human Services’ Office of ...

ByVedanta Biosciences, Inc


Occupational Asthma and Identifying Respiratory Irritants, Allergens and Asthma Triggers

Occupational Asthma and Identifying Respiratory Irritants, Allergens and Asthma Triggers

The New York State Department of Health (NYSDOH) reports that in at least one out of every six asthmatics, their condition is caused or made worse by workplace exposures. ...

ByCochrane & Associates, LLC

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT